ENVESTNET ASSET MANAGEMENT INC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 241 filers reported holding BEAM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$243,939
-49.9%
10,143
-33.4%
0.00%
Q2 2023$486,645
+23.5%
15,241
+18.5%
0.00%
Q1 2023$393,896
+32.2%
12,864
+68.8%
0.00%
Q4 2022$298,018
+12.0%
7,620
+36.6%
0.00%
Q3 2022$266,000
+30.4%
5,580
+57.1%
0.00%
Q1 2022$204,000
-52.7%
3,552
-28.2%
0.00%
Q3 2021$431,0004,9500.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$189,105,00091.90%
PATHWAY CAPITAL MANAGEMENT, LP 37,399$2,993,00016.59%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,390$17,960,00010.54%
HSG Holding Ltd 796,089$63,719,0004.73%
DC Investments Management, LLC 21,010$1,682,0004.17%
Monashee Investment Management LLC 268,820$21,516,0003.31%
Redmile Group, LLC 2,532,523$202,703,0002.86%
HAMILTON LANE ADVISORS LLC 98,761$7,905,0002.58%
Alphabet Inc. 640,792$51,289,0002.07%
Casdin Capital, LLC 818,820$65,538,0001.95%
View complete list of BEAM THERAPEUTICS INC shareholders